Sphingolipids and glycerophospholipids – The “ying and yang” of lipotoxicity in metabolic diseases

• Published in: Progress in lipid research Vol. 66; pp. 14 - 29
• Main Authors: Rodriguez-Cuenca, S., Pellegrinelli, V., Campbell, M., Oresic, M., Vidal-Puig, A.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.04.2017
• Subjects: Animals; Cell Membrane - metabolism; Glycerophospholipids; Glycerophospholipids - metabolism; Humans; Lipotoxicity; Metabolic Diseases - etiology; Metabolic Diseases - metabolism; Metabolic Diseases - pathology; Signal Transduction; Sphingolipids; Sphingolipids - metabolism; C1P; PS; CERK; PLC; SRE; PLD; Sphingolipids; Glycerophospholipids; HDL; S1P; PI3K; SM; SREBP1; Lipotoxicity; AA; CCTα; PLA2; AKT; SMase; PC; TG; PAF; PE; Sphk1; PH; SMS; PI; SPTLC; CERT; CerS
• ISSN: 0163-7827; 1873-2194; 1873-2194
• DOI: 10.1016/j.plipres.2017.01.002

Sphingolipids in general and ceramides in particular, contribute to pathophysiological mechanisms by modifying signalling and metabolic pathways. Here, we present the available evidence for a bidirectional homeostatic crosstalk between sphingolipids and glycerophospholipids, whose dysregulation contributes to lipotoxicity induced metabolic stress. The initial evidence for this crosstalk originates from simulated models designed to investigate the biophysical properties of sphingolipids in plasma membrane representations. In this review, we reinterpret some of the original findings and conceptualise them as a sort of “ying/yang” interaction model of opposed/complementary forces, which is consistent with the current knowledge of lipid homeostasis and pathophysiology. We also propose that the dysregulation of the balance between sphingolipids and glycerophospholipids results in a lipotoxic insult relevant in the pathophysiology of common metabolic diseases, typically characterised by their increased ceramide/sphingosine pools.